title: Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice.
abstract: A recombinant fusion protein composed of Yersinia pestis fraction 1 capsule (F1) and virulence-associated V antigen (V) (F1-V) has been developed as the next-generation vaccine against plague. In this study, female Swiss Webster mice received a single intramuscular vaccination with one of eight doses of the F1-V vaccine and exposed 4 weeks later to either Y. pestis CO92 or C12 organisms by the subcutaneous or aerosol routes of infection. Quantitative anti-F1 and anti-V immunoglobulin G (IgG) ELISAs were used to examine the relationship between survival outcome and antibody titers to F1 and V. Results suggested that each 1log(10) increase in week 4 quantitative anti-F1 and anti-V IgG ELISA titers were associated with a 1.7-fold (p=0.0051) and 2.5-fold (p=0.0054) increase in odds of survival, respectively, against either bubonic or pneumonic plague and may serve as serological correlates of protection.
authors.affiliation: Bacteriology Division, United States Army Medical Research Institute of Infectious Disease (USAMRIID), Fort Detrick, Frederick, MD 21702, USA. stephen.little@amedd.army.mil
authors.forename: S F
authors.initials: SF
authors.lastname: Little
authors.forename: W M
authors.initials: WM
authors.lastname: Webster
authors.forename: H
authors.initials: H
authors.lastname: Wilhelm
authors.forename: D
authors.initials: D
authors.lastname: Fisher
authors.forename: S L W
authors.initials: SL
authors.lastname: Norris
authors.forename: B S
authors.initials: BS
authors.lastname: Powell
authors.forename: J
authors.initials: J
authors.lastname: Enama
authors.forename: J J
authors.initials: JJ
authors.lastname: Adamovicz
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood*; D000942:Antigens, Bacterial / Q000276:immunology*; D001426:Bacterial Proteins / Q000276:immunology*; D015415:Biomarkers; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods*; D005260:Female; D007074:Immunoglobulin G / Q000097:blood; D051379:Mice; D010930:Plague / Q000517:prevention & control*; D052899:Pore Forming Cytotoxic Proteins / Q000276:immunology*; D011993:Recombinant Fusion Proteins / Q000276:immunology; D016019:Survival Analysis; D015010:Yersinia pestis / Q000276:immunology*
chemical_list: D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D015415:Biomarkers; D007074:Immunoglobulin G; C043908:LcrV protein, Yersinia; D052899:Pore Forming Cytotoxic Proteins; D011993:Recombinant Fusion Proteins; C086725:caf1 protein, Yersinia pestis